A phase 2 study to assess olaparib by homologous recombination deficiency status in patients with platinum-sensitive, relapsed, ovarian, fallopian tube, or primary peritoneal cancer Meeting Abstract
| Authors: | Cadoo, K. A.; Aghajanian, C.; Fraser, C.; Milner, A.; Kolvenbag, G. |
| Abstract Title: | A phase 2 study to assess olaparib by homologous recombination deficiency status in patients with platinum-sensitive, relapsed, ovarian, fallopian tube, or primary peritoneal cancer |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 312s |
| Language: | English |
| ACCESSION: | WOS:000411931704083 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS5606 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS5606 -- Source: Wos |
